JP2006506345A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506345A5
JP2006506345A5 JP2004533274A JP2004533274A JP2006506345A5 JP 2006506345 A5 JP2006506345 A5 JP 2006506345A5 JP 2004533274 A JP2004533274 A JP 2004533274A JP 2004533274 A JP2004533274 A JP 2004533274A JP 2006506345 A5 JP2006506345 A5 JP 2006506345A5
Authority
JP
Japan
Prior art keywords
acid
aqueous pharmaceutical
pharmaceutical formulation
inhaler
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004533274A
Other languages
English (en)
Japanese (ja)
Other versions
JP4602767B2 (ja
JP2006506345A (ja
Filing date
Publication date
Priority claimed from DE10237232A external-priority patent/DE10237232A1/de
Application filed filed Critical
Priority claimed from PCT/EP2003/008221 external-priority patent/WO2004022052A1/de
Publication of JP2006506345A publication Critical patent/JP2006506345A/ja
Publication of JP2006506345A5 publication Critical patent/JP2006506345A5/ja
Application granted granted Critical
Publication of JP4602767B2 publication Critical patent/JP4602767B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004533274A 2002-08-14 2003-07-25 抗コリン作用薬を含有する吸入用エアロゾル製剤 Expired - Fee Related JP4602767B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (de) 2002-08-14 2002-08-14 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE10240257 2002-08-31
PCT/EP2003/008221 WO2004022052A1 (de) 2002-08-14 2003-07-25 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Publications (3)

Publication Number Publication Date
JP2006506345A JP2006506345A (ja) 2006-02-23
JP2006506345A5 true JP2006506345A5 (enExample) 2006-09-14
JP4602767B2 JP4602767B2 (ja) 2010-12-22

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004533274A Expired - Fee Related JP4602767B2 (ja) 2002-08-14 2003-07-25 抗コリン作用薬を含有する吸入用エアロゾル製剤

Country Status (31)

Country Link
EP (2) EP1908468A1 (enExample)
JP (1) JP4602767B2 (enExample)
KR (1) KR101060972B1 (enExample)
CN (1) CN1674887A (enExample)
AT (1) ATE400265T1 (enExample)
AU (1) AU2003298473B9 (enExample)
BR (1) BR0313457A (enExample)
CA (1) CA2495275C (enExample)
CY (1) CY1108776T1 (enExample)
DE (1) DE50310117D1 (enExample)
DK (1) DK1530464T3 (enExample)
EA (1) EA009936B1 (enExample)
EC (1) ECSP055600A (enExample)
ES (1) ES2305479T3 (enExample)
HR (1) HRP20050132A2 (enExample)
IL (1) IL166814A (enExample)
MX (1) MXPA05001595A (enExample)
MY (1) MY142579A (enExample)
NO (1) NO20051287L (enExample)
NZ (1) NZ538743A (enExample)
PE (1) PE20040372A1 (enExample)
PL (1) PL375511A1 (enExample)
PT (1) PT1530464E (enExample)
RS (1) RS51396B (enExample)
SA (1) SA03240265B1 (enExample)
SI (1) SI1530464T1 (enExample)
TW (1) TWI317279B (enExample)
UA (1) UA81775C2 (enExample)
UY (1) UY27938A1 (enExample)
WO (1) WO2004022052A1 (enExample)
ZA (1) ZA200410325B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005001297A1 (de) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055958A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
US10508280B2 (en) 2014-01-31 2019-12-17 AgBiome, Inc. Modified biological control agents and their uses
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
HUE058904T2 (hu) 2014-05-07 2022-09-28 Boehringer Ingelheim Int Porlasztókészülék
US10722666B2 (en) 2014-05-07 2020-07-28 Boehringer Ingelheim International Gmbh Nebulizer with axially movable and lockable container and indicator
CA2948071C (en) 2014-05-07 2022-08-30 Boehringer Ingelheim International Gmbh Container, nebulizer and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
EE05167B1 (et) * 2000-05-22 2009-06-15 Chiesi Farmaceutici S.P.A. Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10063957A1 (de) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern

Similar Documents

Publication Publication Date Title
CA2540174A1 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
CA2495275A1 (en) Aerosol formulation for inhalation comprising an anticholinergic agent
US7652030B2 (en) Compositions for treatment of common cold
JP2003504368A5 (enExample)
US20210077382A1 (en) Compositions, devices, and methods for the treatment of opioid-receptor-mediated conditions
JP2005505569A5 (enExample)
CA2531847A1 (en) Hfc solution formulations containing an anticholinergic
KR20120046215A (ko) 소아를 위한 올로파타딘 비강 스프레이 요법
KR20020016831A (ko) 비내용 모르핀을 함유하는 의약 조성물 및 그 제조방법
US20190262329A1 (en) Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
CN102905689A (zh) 包含低剂量纳曲酮的液体鼻喷雾
CN101208091A (zh) 促进口腔吸收的麻醉药的固体药制剂
WO2005102275B1 (en) Galantamine salts, method of producing it and nasal composition thereof
SI1940349T1 (en) Aerosol formulation for inhalation of beta agonists
CN1735434A (zh) 用于预防和治疗伤风与类流感症状的包含精选粘附聚合物的组合物
US6538035B2 (en) Use of tolterodine to treat asthma
WO2014158119A1 (en) Aqueous solution composition containing ipratropium and oxymetazoline
WO2004006929A1 (ja) 経鼻吸収用組成物
JP2011524366A (ja) 鼻内投与のためのケトロラクの薬学的処方物
EP3897579A1 (en) Compositions, devices, and methods for the treatment of overdose and reward-based disorders
JP2003512415A (ja) ガランタミン及び甘味剤を含む経口液剤
JPH01160916A (ja) ドーパミン経鼻投与製剤
JP2000169378A (ja) 咽頭疾患用組成物
JP2008526917A5 (enExample)
WO2014158118A1 (en) Suspension composition containing ipratropium and oxymetazoline